Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The thalassemias and other inherited disorders of hemoglobin are likely to remain a serious global health problem for the foreseeable future. Currently, they are most frequent in the tropical belt; an assessment of their true frequency and the likely cost of management for the governments of these countries will require a form of micromapping. Over recent years, there has been major progress toward better prevention and management of the thalassemias in richer countries; it is likely that, using the tools of molecular genetics, they will eventually be completely curable, although this is probably a long time in the future.

Original publication

DOI

10.1016/j.hoc.2017.11.008

Type

Journal article

Journal

Hematol Oncol Clin North Am

Publication Date

04/2018

Volume

32

Pages

165 - 175

Keywords

Future control, Future frequency, Global frequency, Malaria, North/South partnerships, Thalassemia, Gene Expression Regulation, Global Health, Hemoglobins, Humans, Incidence, Population Surveillance, Prevalence, Risk Factors, Thalassemia